Cerus (CERS)
(Delayed Data from NSDQ)
$1.80 USD
-0.03 (-1.64%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Cerus Corporation [CERS]
Reports for Purchase
Showing records 1 - 20 ( 69 total )
Company: Cerus Corporation
Industry: Medical - Products
Company: Cerus Corporation
Industry: Medical - Products
SMALL-CAP SQUAWK
Provider: JGR Capital Partners
Company: Cerus Corporation
Industry: Medical - Products
Dropping Coverage Due to Analyst Departure
Provider: WEDBUSH SECURITIES INC.
Company: Cerus Corporation
Industry: Medical - Products
Downgrading from OUTPERFORM to NEUTRAL Following Achievement of Price Target - Maintaining $6.50 PT - Is an ARC Win Already Priced in?
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
3Q15 Recap - Sales Miss - One Step Backward in EU - Two Steps Forward In US with OneBlood - US Rev Ramp Still Anyone''s Guess - Maintain OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
Pleasant P-Code Surprise - Helps Open the Market - May Accelerate Contracting - Difficult to Quantify Near Term Impact - Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
3Q15 Preview - Expecting In-line Results - Focus is on ARC - Top Five Account Dialogue - AABB Meeting Activity Seems Good - Maintain OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
2Q15 Recap - Slightly Better Revenue - EPS Lower - New Positive Signals But US Revenue Still Difficult to Model - Maintain OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
2Q15 Preview - Expecting In-line Results - Encouraged by July US Win Momentum - We Believe More Wins are Teed Up This Year - Maintain OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
1Q15 Shows Progress - Sales In-line - EU Unit Growth Solid - US Tone Sounds Good - NIH Contract Announced - Maintain OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
The Week Ahead in Life Sciences - Upcoming Events for the Week of May 4th
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Cerus Corporation
Industry: Medical - Products
The Week Ahead in Life Sciences - Upcoming Events for the Week of May 4th
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Cerus Corporation
Industry: Medical - Products
1Q15 Preview - Minimal Confidence in 1Q EU Business - Encouraged by the US Post ARC Comments in NEJM Article - Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
4Q14 Sales - 2015 Guide A Little Light Due to Fx - Russia - Volume Guidance Ok
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
4Q14 Preview - Expecting in-Line Financials Driven by Flattish EU Q/Q - Recent US Wins Encouraging - Color on Sales Funnel Will Be Key - Maintain OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
Update Post Capital Raise - Funded for 2+ Yrs of US Launch - Lowering 2015 Estimates Related to Implementation Nuances - Maintain OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
LIFE SCIENCES AND HEALTH CARE-2015 Health Care Sector Outlooks
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Cerus Corporation
Industry: Medical - Products
Santa Arrives Early - Brings FDA Approval of Platelet Product 2 Days After Plasma Approval - a Quarter Early - Raising PT from $6.50 to $7.50
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
LIFE SCIENCES AND HEALTH CARE - The Week Ahead in Life Sciences- Upcoming Events for the Week of Dec 22
Provider: WEDBUSH SECURITIES INC.
Company: Cerus Corporation
Industry: Medical - Products
Upping PT to $6.50 on Further De-risking Post Plasma FDA Approval
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z